Glaxosmithkline | GSK - Pre Utilidad Fiscal

Precio De Mercado
51.84
Cambio Diario
-7.28 -12.31%
Mensual
-12.52%
Anual
32.68%
Q2 Expectativa
53.52




Pre Utilidad Fiscal Cambio Fecha
AbbVie USD 5.57B 2.9B 2026-03
Amgen USD 1.51B 2.41B 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bausch Health Companies USD 56M 162M 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Drreddys Laboratories INR 15.43B 1.96B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Glaxosmithkline GBP 2.46B 569M 2025-09
J&J USD 7.82B 2.86B 2026-03
Merck USD 3.42B 3.32B 2025-12
Novartis USD 4.64B 445M 2025-12
Pacira USD 571K 8.95M 2025-12
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 61.81M 7.32M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Takeda JPY 133.86B 105.69B 2025-12
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Zoetis USD 887M 15M 2025-09